 |
From
left: Roger Brechner, SF Chapter and Support Group Manager,
Carol Feghali-Bostwick, SF Board Member, and Frannie
Waldron, SF CEO |
Members
and staff from the Scleroderma Foundation traveled to Washington,
D.C. this week to meet with elected and appointed federal
officials to advocate the need for increased federal funding
for scleroderma.
The
visit kicked off when Foundation CEO Frannie Waldron and Foundation
board member and researcher Carol Feghali-Bostwick attended
a meeting of National Institute of Arthritis and Musculoskeletal
and Skin Diseases (NIAMS). |